MARKET
IPO

ETRA

Electra Therapeutics
ETRA
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-09-18
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
855.40M~977.60M
-
2026-08-28
Public Filing
View Prospectus
Pending
Offering
Price Range: 14.00~16.00
Shares to be Issued: 21.67M
2026-09-17
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 61.10M
2026-09-18
Listed
No Data
About ETRA
Electra Therapeutics Inc is a United States-based clinical- stage biotechnology company. The Company is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Its ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells and precisely depletes pathological immune cells.

Webull offers Electra Therapeutics stock information, including NASDAQ: ETRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ETRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ETRA stock methods without spending real money on the virtual paper trading platform.